RESECT: A Randomised Controlled Trial of Audit and Feedback in Non–muscle-invasive Bladder Cancer Surgery
Publication date
2026-04
Authors
Gallagher, Kevin
MacLennan, Steven
Bhatt, Nikita
Clement, Keiran
Zimmermann, Eleanor
Khadhouri, Sinan
Kulkarni, Meghana
Gaba, Fortis
Anbarasan, Thineskrishna
Asif, Aqua
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Background and objective We aimed to determine whether audit, feedback, and education improves surgical performance after transurethral resection of bladder tumour surgery for non–muscle-invasive bladder cancer and as a secondary aim if it reduced recurrence rates. Methods This cluster randomised controlled trial compared audit and feedback plus peer comparison and education, with audit alone for four coprimary outcomes: (1) Single-instillation chemotherapy, (2) detrusor muscle sampling, (3) documentation of tumour features, and (4) resection completeness. Early recurrence was a secondary outcome. Key findings and limitations A total of 100 sites were randomised to intervention and 101 to control. In total, 14 915 patients were included. Intervention sites significantly improved documentation of tumour features (adjusted mean difference [95% confidence interval {CI}]: 6.0 [1.8, 10], p = 0.005) and of resection completeness (adjusted mean difference [95% CI]: 5.5 [1.5, 9.5], p = 0.007). There was no statistically significant difference in chemotherapy use (adjusted mean difference [95% CI]: 0.3 [–4.7, 5.3], p = 0.9) or detrusor muscle sampling (adjusted mean difference [95% CI]: 2.6 [–1.3, 6.4], p = 0.2). There was no statistically significant difference in early recurrence rate between arms (adjusted odds ratio [95% CI]: 1.02 [0.8, 1.4], p = 0.9); however, in the control arm, the early recurrence rate reduced compared with baseline (adjusted odds ratio [95% CI]: 0.7 [0.6, 0.9]). Conclusions and clinical implications Audit and feedback with education improved the documentation of important surgical findings that influence clinical management, but not the performance of detrusor muscle sampling, adjuvant chemotherapy use, or early recurrence rates. Improvements observed in the control arm may explain a lack of effect of the intervention in some outcomes.
Keywords
Audit and feedback, Implementation science, Non–muscle-invasive bladder cancer, Quality improvement, Quality performance indicators, Urology
Citation
Gallagher, K, MacLennan, S, Bhatt, N, Clement, K, Zimmermann, E, Khadhouri, S, Kulkarni, M, Gaba, F, Anbarasan, T, Asif, A, Light, A, Ng, A, Chan, V W S, Nathan, A, Cooper, D, Aucott, L, Sakthivel, D, Akand, M, Piazza, P, Marcq, G, O’Brien, T, Nielsen, M, Giudice, F D, Simpson, K, Orecchia, L, Teixeira, B, Dawam, D, Geisenhoff, A, Hill, G, Fukuokaya, W, Hidalgo, B G, El-Hajj, A, Elgamal, M, Fanshawe, J, Wang, B, Lee, T, Manecksha, R, McCann, C, Rivas, J G, Arda, E, Elhadi, M, Rossi, S, Teoh, J Y C, Mariappan, P, Kasivisvanathan, V, Princiotta, A A, Trabacchin, N, Costa, P, Maessen, A W, Willemse, P P M & The RESECT Global Study Group 2026, 'RESECT : A Randomised Controlled Trial of Audit and Feedback in Non–muscle-invasive Bladder Cancer Surgery', European Urology, vol. 89, no. 4, pp. 355-365. https://doi.org/10.1016/j.eururo.2025.09.4174